Petit, Centre National de la Recherche Scientifique (CNRS), France Reviewed by Mrcio Simo, University of Algarve, Portugal Fangyang Fan, Beijing University of Chinese Medicine, China Updates Copyright 2024 Lu, Liu, Qi, Wang, Chang, Bai, Jiao, Chen and Zhen
Understanding the research landscape The science of GLP-1 medications and hair loss is still evolving
For elite athletes or bodybuilders who've exhausted natural potential and understand the trade-offs, steroids might make sense under proper medical supervision
In CTR-1011, injection-site issues happened in 50.7% of tesamorelin users versus 21.4% on placebo
Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study
SIBO is characterised by an abnormal increase in bacteria (typically gram-negative organisms from the colon) in the small intestine